View
226
Download
0
Embed Size (px)
Citation preview
Chapter 12: Single-Subject Designs An alternative to experimental designsPurpose: To draw conclusions about the effects of
treatment based on the responses of a single patient under controlled conditions.
Based on: A research hypothesis indicating expected
relationship between independent and dependent variables
Specific operational definitions
Single-Subject Designs
Independent Variable-The intervention
Dependent Variable- The patient response (defined as the
target behavior) Target behavior is observable,
quantifiable, and a valid indicator of treatment effectiveness
Single-Subject Designs
Can be used to study comparisons between:
Several treatments Components of treatments Treatment and no-treatment conditions
Structure of Single-Subject Designs
Repeated Measurement Systematic collection of repeated
measurements of a behavioral response over time
These repeated assessment are required to observe trends or patterns and evaluate variability of the behavioral responses over time
Design Phases
Delineation of at least two testing periods:
• Baseline phase
• Intervention phase
• Target behavior is measured across both phases
Design Phases
Baseline information: Responses of target behavior during a period
of “no treatment” Reflects the target behavior over time in the
absence of the independent variable (intervention)
Changes from baseline to the intervention phase are attributed to the intervention
Design Phases
Design phases are plotted on a line graph
Magnitude of the target behavior along the Y-axis
Time (sessions, trial, days, weeks) along the X-axis
Baseline is represented by the letter A Intervention by the letter B
Design Phases
The design of one baseline period followed by one intervention period is: A- B design
Baseline data collection Unique to Single-Subject Design (all other designs treatment is initiated
following assessment)
Baseline Data Collection
Traditional designs make it impossible to determine:
Which component of treatment actually caused observed changes
If observed changes would have occurred without intervention
Baseline Data Collection
Baseline phase is a control period replacing a control group
Ethical considerations and baseline phase
Not unethical to withdraw treatment for a short period when we are not sure of effectiveness of treatment
Baseline Characteristics
Two characteristics of baseline data are important for interpretation of clinical outcomes:
• Stability- Consistency of response over time
• Trend- (slope) Shows the rate of change in the behavior
Baseline Characteristics
The most desirable baseline pattern demonstrates:– A constant level of behavior– Minimal variabilityIndicating: Target behavior is not
changingTherefore: Observable changes after
intervention are due to intervention
Baseline Characteristics
A variable baseline can present a problem for interpretation.
An Accelerating baseline-an increasing rate of response
A decelerating baseline-a decelerating rate of response
In both cases: a change in target behavior is occur13ring without intervention
Length of Phases
Flexibility in considerations depending on:– Type of patient– Type of treatment– Expected rate of change in the target
behavior
It is essential that the length of time within each phase is sufficient to capture any changes
Target Behavior
Can reflect:– Different response systemsMay focus on:
Impairmentsfunctional limitationsmeasures of disabilities
Measurements may deal with overt motor behaviors- functional performance, ROM, gait characteristics
Measuring Target Behavior
Frequency Duration Magnitude
Frequency
Counting the # of occurrences of the behavior within:
»A fixed time interval»Fixed number of trials»“Frequency count” is the simplest
of all behavioral measures
Frequency
Frequency count is appropriate to assess a discrete clinical behavior– Examples: – # of times a particular gait deviation occurs– # of times a client can repeat an exercise– # of times a patient loses her balance
during a treatment session
Frequency
Operational definitions for frequency counts must specify:– How the target behavior is distinguished
from other responses– What constitutes an occurrence and
nonoccurrence– (partial completion of exercise? fall over
but catching oneself?)
Frequency
“Frequency counts” are not useful when:– A behavior occurs too often to be counted
reliably– A behavior lasts for a long time (occurs too
seldom) The total time or total number of trials within
which the count is made must remain constant across sessions
Frequency
“Frequency counts” do not account for the quality of the behavior but only that it occurred
“Frequency counts” can be expressed as:– A percentage
• Dividing # of occurrences by total # of opportunities (percentage correct)
Frequency
Percentages are useful in that they are: Easily understood Efficient for summarizing large # of
responses Yet: If actual # of correct responses is
an indicant of the target behavior, percentage can be misleading
Frequency
“Frequency counts” can be translated into “rates”– The number of times a behavior occurs
within a specific time period (seconds, minutes, hours)
– Dividing the total # of occurrences by the total time
– (Ambulation in steps per minute)
Duration
Target behaviors can be measured according to how long they last
Duration can be measured either as:– The cumulative total duration of a behavior
during a treatment session– The duration of each individual
occurrences of the behavior
Duration
How long a patient stays in a balanced standing posture within:– A treatment session– Or:– Time how long it takes for a patient to
complete a functional task
Duration
Can be reported in terms of percentages
“Percentage time in zone”– (Dividing total time in the desired zone by
total time of training session)– This approach is useful when sessions are
not of equal length
Magnitude
Many clinical variables (target behaviors) are measured using instrumentation that provides quantitative data
(Electrical, functional performance)
Interval Recording for Observational Measures
Target behavior are usually recorded using either:– Quantitative instrumentation
• Appropriate for magnitude measure• Objective
– Self-report• Monitor activities outside the clinical
environment
– Direct observation
Interval Recording
Often recorded using frequency & duration methods to record the occurrence or nonoccurrence of the behavior
Certain behaviors are difficult to quantify– Break down the measurement period into preset
time intervals– Determine if behavior occur or does not occur
during each interval period (5 minutes)
Interval Recording
Sometimes called “time sampling” Total session time is divided into small
equal intervals Measurement may involve:
– Recording the presence/absence of the target behavior within each interval, and then tallying how many intervals contained the behavior
Interval recording
– Recording the frequency or duration of the behavior within each each interval
– It is important to select a time interval that will best reflect the expected frequency and duration of the behavior
– Requires the use of a signaling device
Reliability
Reliability is usually assessed concurrently with data collection, rather than in a separate pilot study
Reliability checks are performed by using two testers simultaneously observe the target behavior at several sessions across each phase
Reliability
Interrater reliability is usually reported using a measure of percentage agreement between observers
Total Reliability– Total steps: A=25; B=28; – Total reliability: (25/28)x 100= 89%– Limitation: Reflects only the consistency of the
total score for a session, but may observe different instances of the behavior
Reliability
Point-by-Point/Interval-by-Interval/Trial-by Trial
Agreement is based on: Number of occasions on which the observers agree that a behavior occurred or not occurred is divided by total occasions that raters agree and disagree
Total 30 trials observers agreed on 29: Trial-by-trial: (29/30) x 100= 97%
Reliability
Interval-by-interval– Of 16 intervals (15 minutes), observers
disagreed on 3 times (intervals 3,5,11)– (13/16)x 100= 81%– Chance agreement – Kappa – provides a statistical measure
Experimental Control
1. A-B: Baseline-Intervention (before-after)
2. A-B-A: Baseline-Intervention-Baseline (Withdrawal design)
If changes in behavior are not maintained during the second baseline phase- changes are due to intervention
3. A-B-A-B: In 3, 4 designs, behavior must be reversible
Experimental Control
Multiple Treatment Design1. A-B-C-B: Two treatments have independent
and differential effects2. A-B-A-C: A second baseline phase between
two treatments3. A-B-C-A-C-B: Sequential relationship
between B and C, and examine each treatment effect after baseline
4. A-B-C-BC: Combined phase
Data Analysis
Analysis is based on evaluation of measurements within and across design phases to determine if:
• Behaviors are changing• Observed changes during intervention are
associated with the onset of treatment
Data Analysis
1. Visual analysis– No mathematical operations– Intuitively meaningful– Data within a phase are described according to:
» Stability or variability» Trend- direction of change» Level- changes in magnitude (the value
of the behavior) from last data point of one phase to another
Data Analysis-Visual Analysis
Trend- direction of change within a phase• Accelerating or decelerating • Stable (constant) rate of change• Linear or curvilinear
A trend in baseline data:• No serious problem if against what is expected during
intervention• A slope of a trend can only be determined for linear data
Single-Subject Design
Now you know all about single-subject design